A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

Innovative platform trial revolutionizes ALS research by testing multiple treatments simultaneously, offering new hope ...

Legendary American singer, Roberta Flack, recently passed away at the age of 88, three years after being diagnosed with motor neurone disease in 2022.According to a statement from her family, the ...

At 2 years, more untreated controls died than those treated with IV edaravone. Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV ...

Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives ...

IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer ...

ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

Edaravone dexboneol (Eda.B) is clinically used in China for acute ischemic stroke management as a brain protectant. It consists of two ingredients, edaravone and (+)-dexborneol, exerting antioxidant, ...

However, edaravone is a promising therapeutic agent, although its beneficial effects are inconclusive based on previous systematic reviews and meta-analyses. While several trials in the last 8 years ...

Background: Edaravone dexborneol is a novel cytoprotective agent widely used for acute ischemic stroke patients in clinical practice in China. It is unclear whether minor stroke patients benefit from ...

While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows ...